140 studies found for:    N-methyl-D-aspartate receptor (NMDAR)
Show Display Options
Rank Status Study
1 Completed
Has Results
Behavioral and Cognitive Effects of the N-methyl-D-aspartate Receptor (NMDAR) Co-agonist D-serine in Healthy Humans
Condition: Healthy
Interventions: Other: D-serine;   Other: Placebo
2 Active, not recruiting Multicenter and Prospective Clinical Registry Study of Anti-N-methyl-D-aspartate Receptor Encephalitis in China
Condition: Anti-NMDA Receptor Enphalitis
Intervention:
3 Completed D-cycloserine for Major Depressive Disorder
Condition: Major Depressive Disorder
Intervention: Drug: D-cycloserine
4 Recruiting Multicenter and Prospective Clinical Registry Study of Anti-N-methyl-D-aspartate Receptor Encephalitis in Beijing Area
Condition: Anti-N-Methyl-D-Aspartate Receptor Encephalitis
Intervention:
5 Terminated SPECT Investigation Of The NMDA Receptor System In Healthy Volunteers And Patients With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: [123]I-CNS 1261;   Drug: Lorazepam;   Drug: Risperidone
6 Completed Transcranial Direct Current Stimulation on Cortical Plasticity in Patients With Anti-NMDA Receptor Encephalitis
Condition: Anti-NMDA Receptor Encephalitis
Interventions: Device: tDCS;   Device: Sham Stimulation
7 Unknown  Hyperalgesia and NMDA Receptor Antagonist
Condition: Pain
Interventions: Drug: Magnesium Sulfate;   Drug: ketamine
8 Active, not recruiting Facilitation of NMDA Receptor Function in Patients With Schizophrenia and Co-morbid Alcoholism
Conditions: Alcoholism;   Schizophrenia
Intervention: Drug: Glycine
9 Unknown  Effects of N-Methyl-D-Aspartate (NMDA)-Receptor Antagonism on Hyperalgesia, Opioid Use, and Pain After Radical Prostatectomy
Conditions: Hyperalgesia;   Pain;   Prostate Cancer
Intervention: Drug: Amantadine
10 Unknown  Effects of Ketamine and Risperidone on Cognition
Conditions: Healthy Volunteers;   Schizophrenia
Interventions: Drug: ketamine;   Drug: risperidone;   Drug: saline;   Drug: placebo to match risperidone
11 Completed Effects of GLYX-13 on Learning and Memory in Healthy Individuals and Those With Psychiatric Illness
Condition: Learning and Memory in Healthy Individuals and Those With Psychiatric Illness
Interventions: Drug: GLYX-13;   Drug: Placebo
12 Recruiting A Novel Drug for Borderline Personality Disorder
Condition: Borderline Personality Disorder
Interventions: Drug: NMDA receptor antagonist (active drug);   Other: Lactose packed capsule (inert/inactive arm)
13 Completed Acamprosate: Genes Associated With Response
Condition: Alcoholism
Intervention: Drug: acamprosate
14 Completed The Influence of Glutamate on Memory in Humans
Condition: Healthy Individuals
Interventions: Drug: Sugar pill;   Drug: Glutamic Acid;   Drug: Memantine
15 Completed Biomarker Study of Acamprosate in Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder
Intervention: Drug: Acamprosate
16 Completed Dextromethorphan Versus Placebo for Neuropathic Pain
Conditions: Diabetic Neuropathies;   Herpes Zoster;   Neuralgia
Intervention: Drug: dextromethorphan
17 Completed Study of Memantine for Gait Disorders And Attention Deficit In Parkinson's Disease
Conditions: Parkinson's Disease;   Gait Disorders, Neurologic
Interventions: Drug: memantine;   Drug: placebo
18 Completed Nuedexta in Treatment-Resistant Major Depression
Conditions: Major Depressive Disorder;   Treatment Resistant
Intervention: Drug: dextromethorphan/quinidine
19 Completed The Safety and Efficacy of Neramexane in Patients With Moderate to Severe Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Neramexane
20 Terminated Phase II Open-Label Pilot Study of V3381 in Chronic Cough
Condition: Cough
Intervention: Drug: Indantadol

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years